FDA Label for Lymeplex
View Indications, Usage & Precautions
Lymeplex Product Label
The following document was submitted to the FDA by the labeler of this product King Bio Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Drug Facts​__________________________________________________________________________________________________________
HPUS active ingredients: Baptisia tinctoria, Belladonna, Bryonia, Calcarea carbonica, Calcarea fluorica, Eupatorium perfoliatum, Gelsemium sempervirens, Kali carbonicum, Mercurius vivus, Rhus toxicodendron​. Equal volumes of each ingredient in 10X, 30X, 100X, 1M, LM1, LM2, LM3 potencies.
Indications & Usage
Uses for temporary relief of: rash, chills, fatigue, low-grade fever, swelling, aching or stiffness in joints or muscles associated with insect bites.
Inactive Ingredient
Inactive Ingredients:
Bio-Energetically Enhanced™ pure water, citric acid and potassium sorbate.
Warnings
Warnings
- Stop use and ask your doctor if symptoms persist or worsen.
- If pregnant or breast-feeding, take only on advice of a healthcare professional.
Otc - Keep Out Of Reach Of Children
- Keep out of reach of children.
Dosage & Administration
Directions
- Initially, depress pump until primed.
- Spray one dose directly into mouth.
- Adults: 3 sprays 3 times per day.
- Children 2-12 years: 2 sprays 3 times per day.
- Use additionally as needed, up to 6 times per day.
Other Safety Information
Tamper resistant for your protection. Use only if safety seal is intact.
Otc - Purpose
Uses for temporary relief of:
- rash
- chills
- fatigue
- low-grade fever
- swelling
- aching or stiffness in joints or muscles associated with insect bites
Package Label.Principal Display Panel
* Please review the disclaimer below.